A Collaborative Effort: How Parallel Approaches And Diverse Partnerships Could Help Combat COVID-19
Source: Catalent

The COVID-19 virus is arguably the most challenging global healthcare crisis of our time. In a panel discussion, executives from Moderna, Sanofi Pasteur, Takeda, and Catalent shared behind-the-scenes updates on their respective efforts to develop a COVID-19 vaccine. While their approaches are different, the companies have all adopted a collaborative mindset to arrive at a vaccine as quickly and safely as possible.
VIEW THE E-BOOK!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.
Subscribe to Bioprocess Online
X
Subscribe to Bioprocess Online
Catalent
This website uses cookies to ensure you get the best experience on our website. Learn more